Novo Nordisk

Ozempic® is the first-and-only medication indicated for both the once-weekly treatment of adult patients with type 2 diabetes…

Ozempic® is the GLP-1 with the most FDA-approved uses for patients with type 2 diabetes including, improvement of…

(Reuters) -European shares were little changed in early trade on Monday, with investors on the watch for Ukraine…

“Today’s decision by the FDA reflects the continued progress in how we understand and treat patients with MASH,…

Wegovy is now available in Singapore more than two years after it was approved by the Health Sciences…

Quantum technology is becoming very important for both business and global power. In the last ten years, the…

WERNERSVILLE, Pa. — To make sense of the reds and greens dancing across a computer monitor displaying a…

Last week, many media outlets reported on a press release from the UK Medicines and Healthcare products Regulatory…

With the launch of Wegovy by Novo Nordisk in India, the country’s obesity drugs sector is all set…

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s…

Health Canada approves Ozempic® to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease